Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale-Reference-Cited by-同舟云学术

Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale

Published:2018-07-10 Issue:12 Volume:14 Page:1565-1571
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Navitsky Michael¹,Joshi Abhinay D.¹,Kennedy Ian¹,Klunk William E.²,Rowe Christopher C.³,Wong Dean F.⁴,Pontecorvo Michael J.¹,Mintun Mark A.¹,Devous Michael D.¹

Affiliation:

1. Avid RadiopharmaceuticalsPhiladelphiaPAUSA

2. Departments of Neurology and PsychiatryUniversity of Pittsburgh School of MedicinePittsburghPAUSA

3. Department of Molecular Imaging and TherapyAustin Health and Department of MedicineUniversity of MelbourneMelbourneVictoriaAustralia

4. RadiologyPsychiatryNeuroscienceNeurologyEnvironmental Health SciencesCarey Business SchoolJohns Hopkins UniversitySection of High Resolution Brain PET ImagingDivision of Nuclear MedicineBaltimoreMDUSA

Funder

National Institutes of Health

Johnson and Johnson

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.06.1353

Reference20 articles.

1. Brain Amyloid Imaging

2. Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

3. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

4. Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

5. Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tau PET positivity predicts clinically relevant cognitive decline driven by Alzheimer’s disease compared to comorbid cases; proof of concept in the ADNI study;Molecular Psychiatry;2024-08-23

2. Recent Insights into the Neurobiology of Alzheimer’s Disease and Advanced Treatment Strategies;Molecular Neurobiology;2024-08-05

3. Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology;Alzheimer's & Dementia;2024-07-04

4. Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretation;Alzheimer's & Dementia;2024-07-04

5. Trajectories of amyloid beta accumulation – Unveiling the relationship with APOE genotype and cognitive decline;Neurobiology of Aging;2024-07